Sunrest Lifescience Ltd
Incorporated in 2017, Sunrest Lifescience Ltd trades in Health care and Cosmetics products[1]
- Market Cap ₹ 30.0 Cr.
- Current Price ₹ 35.0
- High / Low ₹ 54.4 / 26.4
- Stock P/E 17.0
- Book Value ₹ 19.4
- Dividend Yield 0.00 %
- ROCE %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Part of Nifty SME Emerge
Half Yearly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| 33.41 | |
| 30.38 | |
| Operating Profit | 3.03 |
| OPM % | 9.07% |
| 0.00 | |
| Interest | 0.31 |
| Depreciation | 0.10 |
| Profit before tax | 2.62 |
| Tax % | 23.28% |
| 2.02 | |
| EPS in Rs | 2.34 |
| Dividend Payout % | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | -28% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| Equity Capital | |
| Reserves | |
| Total Liabilities | |
| CWIP | |
| Investments | |
| Total Assets |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| 2.92 | |
| -1.15 | |
| -0.33 | |
| Net Cash Flow | 1.45 |
| Free Cash Flow | 1.76 |
| CFO/OP | 112% |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2025 | |
|---|---|
| Debtor Days | |
| Inventory Days | |
| Days Payable | |
| Cash Conversion Cycle | |
| Working Capital Days | |
| ROCE % |
Insights
In beta| Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|
| Trade Receivable Turnover Ratio Times ・Standalone data |
|
||
| Medical Representatives (MR) Reimbursement Expense INR Lakhs ・Standalone data |
|||
| Number of Employees Number ・Standalone data |
|||
| Number of Subsidiaries Number ・Standalone data |
|||
Extracted by Screener AI
Documents
Announcements
-
General Updates
14 May 2026 - Board reconstituted Audit Committee and Stakeholders Relationship Committee effective 14 May 2026.
-
Outcome of Board Meeting
14 May 2026 - Board reconstituted Audit and Stakeholders Relationship Committees effective 14 May 2026.
-
General Updates
14 May 2026 - Board meeting on 14 May 2026 reconstituted Audit and Stakeholders Relationship Committees.
-
Outcome of Board Meeting
30 April 2026 - Board dissolved the rights issue on 30 April 2026 due to minimum subscription shortfall and will unblock applicant funds.
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
20 April 2026 - Sunrest Lifescience says corporate governance report not applicable for quarter ended 31 March 2026.
Business Overview:[1][2]
SLSL is in the business of trading of Pharmaceutical Product on wholesale and retail basis. It provides OTC brands in healthcare & personal care viz. Capsules, Tablets, Syrup, Ointment, Gel, mouthwash, Solution, Suspension, Dry Powders, and Toothpaste